60.36
price up icon4.79%   2.76
after-market Handel nachbörslich: 61.03 0.67 +1.11%
loading

Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
26.55%
4.0931
3.2343 3.2218 11.07 1.5749
Operating Income/Loss
26.55%
-4.0931
-3.2343 -3.2218 -11.07 -1.5749
Income/Loss From Continuing Operations Before Tax
40.11%
-3.4376
-2.4535 -2.625 -10.92 -1.3043
Income/Loss From Continuing Operations After Tax
40.11%
-3.4376
-2.4535 -2.625 -10.93 -1.3043
Net Income/Loss
40.11%
-3.4376
-2.4535 -2.625 -10.93 -1.3043
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.80%
7.1238
6.9981 6.9874 0.3709 3.5204
Basic Earnings Per Share
37.14%
-0.48
-0.35 -0.38 -2.75 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):